Active, Not Recruiting
PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia
NCT01589302
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States